Intravenous cyclophosphamide pulse therapy in interstitial lung disease associated with systemic sclerosis in a retrospective open-label study: influence of the extent of inflammation on pulmonary function

Low-dose pulse cyclophosphamide in interstitial lung disease associated with systemic sclerosis (SSc-ILD): Efficacy of maintenance immunosuppression in responders and non-responders.

Iudici M
Bocchino M
Sanduzzi Zamparelli A
CUOMO, Giovanna
VETTORI, Serena
CAPPABIANCA, Salvatore
VALENTINI, Gabriele

January 2015

Objective To investigate the long-term disease course of patients with recently deteriorated system...

Pulmonary hypertension and systemic sclerosis: the role of highresolution computed tomography.

ZOMPATORI, MAURIZIO
LEONE, MARIA BARBARA
GIANNOTTA, MARICA
GALIE', NAZZARENO
PALAZZINI, MASSIMILIANO
BACCHI REGGIANI, MARIA LETIZIA
BONO, LEA
POLLINI, GIAN STEFANO

January 2013

Purpose: This study sought to evaluate, by means of a retrospective analysis, the relationship betwe...

w w w.archbronconeumol.org Letters to the Editor Efficacy of Mycophenolate Associated With Methotrexate as a Maintenance Treatment for Systemic Sclerosis-Associated

Interstitial Lung Disease

October 2016

Eficacia del micofenolato asociado a metotrexato como tratamiento de mantenimiento de la enfermedad ...

[Treatment of systemic sclerosis.]

Hoogen, F.H.J. van den

January 2006

Contains fulltext : 49272.pdf (publisher's version ) (Closed access)Systemic scler...

High-dose prednisolone and bolus cyclophosphamide in interstitial lung disease associated with systemic sclerosis: a prospective open study

Wanchu, Ajay
Suryanaryana, Bettadpura Shamanna
Sharma, Shefal
Sharma, Aman
Bambery, Pradeep

January 2009

Aim: Currently, therapy for interstitial lung disease in patients with systemic sclerosis is unsatis...

Intravenous Cyclophosphamide Pulse Therapy in the Treatment of Systemic Sclerosis-Related Interstitial Lung Disease : A Long Term Study

Simeón-Aznar, Carmen Pilar
Fonollosa Pla, Vicent
Tolosa-Vilella, Carles
Selva-O'Callaghan, A.
Solans-Laqué, Roser
Palliza, E.
Muñoz, Xavier
Vilardell-Tarrés, M.
Universitat Autònoma de Barcelona. Departament de Medicina

January 2008

Interstitial lung disease (ILD) frequently complicates systemic sclerosis (SSc). Cyclophosphamide (C...

Pulmonary arterial hypertension, a novelty in idiopathic inflammatory myopathies: insights and first experiences with vasoactive therapy

Bhansing, K.J.
Vonk-Noordegraaf, A.
Oosterveer, F.P.
Riel, P.L.C.M. van
Vonk, M.C.

January 2017

Contains fulltext : 177244.pdf (publisher's version ) (Open Access)To characterise...

Effect Of Intravenous Pulse Cyclophosphamtoe (CYC) Therapy On Systemic Sclerosis (Ssc) Inflammatory Lung Disease

Weinberg, MD, Nicole
Sandorfi, MD, Nora
Jimenez, MD, Sergio A.

May 2011

Deterioration of lung function is the most frequent causeof death in SSc. Alveolitis is considered t...

Reumatol Clin. 2012;8(2):58–62 www.reumato logiac l in ica.org Original Article Are High Doses of Prednisone Necessary for Treatment of Interstitial Lung Disease in Systemic Sclerosis?

Dionisio Pérez Campos
Miguel Estévez Del Toro
A Aisa Peña Casanovas
B Pedro Pablo González Rojas
Lisvenia Morales Sánchez
C Ángela Rosa Gutiérrez Rojasd

January 2011

High and low doses of prednisone Interstitial lung disease Systemic sclerosis a b s t r a c t Introd...

Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis.

Giacomelli R
Valentini G
Salsano F
Cipriani P
Sambo P
Conforti ML
Fulminis A
De Luca A
Farina G
Candela M
Generini S
De Francisci A
Tirri E
Proietti M
Bombardieri S
Gabrielli A
Tonietti G
Cerinic MM.

January 2002

OBJECTIVE: To evaluate, in a pilot study, the efficacy of a short term cyclophosphamide (CYC) pul...

Long-term effects of immunosuppressive therapy on lung function in scleroderma patients

Pavlov-Dolijanović, Slavica
Vujasinović-Stupar, Nada
Zugić, Vladimir
Ostojić, Predrag
Zeković, Ana
Živanović-Radnić, Tatjana
Jeremić, Ivan
Tadić, Ivana

January 2018

The study aims to analyze the effects of induction treatment with cyclophosphamide (CYC) pulse thera...

Cyclophosphamide-refractory scleroderma-associated interstitial lung disease: remarkable clinical and radiological response to a single course of rituximab combined with high-dose corticosteroids

Muhammad Haroon
Patrick McLaughlin
Michael Henry
Sinead Harney

October 2011

We would like to report our experience of using rituximab in cyclophosphamide refractory, rapidly pr...

Systemic sclerosis: assessment and treatment. TIght control in a tight disease.

Vonk, M.C.

January 2008

Contains fulltext : 70897.pdf (publisher's version ) (Open Access)Systemic scleros...

Therapeutic options for systemic sclerosis related interstitial lung diseases

Mouthon, Luc
Bérezné, Alice
Guillevin, Loïc
Valeyre, Dominique

July 2010

SummaryInterstitial lung disease (ILD) is a common manifestation of systemic sclerosis (SSc) mainly ...

Low-dose pulse cyclophosphamide in interstitial lung disease associated with systemic sclerosis (SSc-ILD): efficacy of maintenance immunosuppression in responders and non-responders

Iudici, Michele
Cuomo, Giovanna
Vettori, Serena
Cappabianca, Salvatore
Valentini, Gabriele
BOCCHINO, MARIALUISA
SANDUZZI ZAMPARELLI, ALESSANDRO

January 2015

To investigate the long-term disease course of patients with recently deteriorated systemic sclerosi...

Low-dose pulse cyclophosphamide in interstitial lung disease associated with systemic sclerosis (SSc-ILD): Efficacy of maintenance immunosuppression in responders and non-responders.

Iudici M
Bocchino M
Sanduzzi Zamparelli A
CUOMO, Giovanna
VETTORI, Serena
CAPPABIANCA, Salvatore
VALENTINI, Gabriele

January 2015

Objective To investigate the long-term disease course of patients with recently deteriorated system...

Pulmonary hypertension and systemic sclerosis: the role of highresolution computed tomography.

ZOMPATORI, MAURIZIO
LEONE, MARIA BARBARA
GIANNOTTA, MARICA
GALIE', NAZZARENO
PALAZZINI, MASSIMILIANO
BACCHI REGGIANI, MARIA LETIZIA
BONO, LEA
POLLINI, GIAN STEFANO

January 2013

Purpose: This study sought to evaluate, by means of a retrospective analysis, the relationship betwe...

w w w.archbronconeumol.org Letters to the Editor Efficacy of Mycophenolate Associated With Methotrexate as a Maintenance Treatment for Systemic Sclerosis-Associated

Interstitial Lung Disease

October 2016

Eficacia del micofenolato asociado a metotrexato como tratamiento de mantenimiento de la enfermedad ...

[Treatment of systemic sclerosis.]

Hoogen, F.H.J. van den

January 2006

Contains fulltext : 49272.pdf (publisher's version ) (Closed access)Systemic scler...

High-dose prednisolone and bolus cyclophosphamide in interstitial lung disease associated with systemic sclerosis: a prospective open study

Wanchu, Ajay
Suryanaryana, Bettadpura Shamanna
Sharma, Shefal
Sharma, Aman
Bambery, Pradeep

January 2009

Aim: Currently, therapy for interstitial lung disease in patients with systemic sclerosis is unsatis...

Intravenous Cyclophosphamide Pulse Therapy in the Treatment of Systemic Sclerosis-Related Interstitial Lung Disease : A Long Term Study

Simeón-Aznar, Carmen Pilar
Fonollosa Pla, Vicent
Tolosa-Vilella, Carles
Selva-O'Callaghan, A.
Solans-Laqué, Roser
Palliza, E.
Muñoz, Xavier
Vilardell-Tarrés, M.
Universitat Autònoma de Barcelona. Departament de Medicina

January 2008

Interstitial lung disease (ILD) frequently complicates systemic sclerosis (SSc). Cyclophosphamide (C...

Pulmonary arterial hypertension, a novelty in idiopathic inflammatory myopathies: insights and first experiences with vasoactive therapy

Bhansing, K.J.
Vonk-Noordegraaf, A.
Oosterveer, F.P.
Riel, P.L.C.M. van
Vonk, M.C.

January 2017

Contains fulltext : 177244.pdf (publisher's version ) (Open Access)To characterise...

Effect Of Intravenous Pulse Cyclophosphamtoe (CYC) Therapy On Systemic Sclerosis (Ssc) Inflammatory Lung Disease

Weinberg, MD, Nicole
Sandorfi, MD, Nora
Jimenez, MD, Sergio A.

May 2011

Deterioration of lung function is the most frequent causeof death in SSc. Alveolitis is considered t...

Reumatol Clin. 2012;8(2):58–62 www.reumato logiac l in ica.org Original Article Are High Doses of Prednisone Necessary for Treatment of Interstitial Lung Disease in Systemic Sclerosis?

Dionisio Pérez Campos
Miguel Estévez Del Toro
A Aisa Peña Casanovas
B Pedro Pablo González Rojas
Lisvenia Morales Sánchez
C Ángela Rosa Gutiérrez Rojasd

January 2011

High and low doses of prednisone Interstitial lung disease Systemic sclerosis a b s t r a c t Introd...

Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis.

Giacomelli R
Valentini G
Salsano F
Cipriani P
Sambo P
Conforti ML
Fulminis A
De Luca A
Farina G
Candela M
Generini S
De Francisci A
Tirri E
Proietti M
Bombardieri S
Gabrielli A
Tonietti G
Cerinic MM.

January 2002

OBJECTIVE: To evaluate, in a pilot study, the efficacy of a short term cyclophosphamide (CYC) pul...

Long-term effects of immunosuppressive therapy on lung function in scleroderma patients

Pavlov-Dolijanović, Slavica
Vujasinović-Stupar, Nada
Zugić, Vladimir
Ostojić, Predrag
Zeković, Ana
Živanović-Radnić, Tatjana
Jeremić, Ivan
Tadić, Ivana

January 2018

The study aims to analyze the effects of induction treatment with cyclophosphamide (CYC) pulse thera...

Cyclophosphamide-refractory scleroderma-associated interstitial lung disease: remarkable clinical and radiological response to a single course of rituximab combined with high-dose corticosteroids

Muhammad Haroon
Patrick McLaughlin
Michael Henry
Sinead Harney

October 2011

We would like to report our experience of using rituximab in cyclophosphamide refractory, rapidly pr...

Systemic sclerosis: assessment and treatment. TIght control in a tight disease.

Vonk, M.C.

January 2008

Contains fulltext : 70897.pdf (publisher's version ) (Open Access)Systemic scleros...

Therapeutic options for systemic sclerosis related interstitial lung diseases

Mouthon, Luc
Bérezné, Alice
Guillevin, Loïc
Valeyre, Dominique

July 2010

SummaryInterstitial lung disease (ILD) is a common manifestation of systemic sclerosis (SSc) mainly ...

Low-dose pulse cyclophosphamide in interstitial lung disease associated with systemic sclerosis (SSc-ILD): efficacy of maintenance immunosuppression in responders and non-responders

Iudici, Michele
Cuomo, Giovanna
Vettori, Serena
Cappabianca, Salvatore
Valentini, Gabriele
BOCCHINO, MARIALUISA
SANDUZZI ZAMPARELLI, ALESSANDRO

January 2015

To investigate the long-term disease course of patients with recently deteriorated systemic sclerosi...

Low-dose pulse cyclophosphamide in interstitial lung disease associated with systemic sclerosis (SSc-ILD): Efficacy of maintenance immunosuppression in responders and non-responders.

Iudici M
Bocchino M
Sanduzzi Zamparelli A
CUOMO, Giovanna
VETTORI, Serena
CAPPABIANCA, Salvatore
VALENTINI, Gabriele

January 2015

Objective To investigate the long-term disease course of patients with recently deteriorated system...

Pulmonary hypertension and systemic sclerosis: the role of highresolution computed tomography.

ZOMPATORI, MAURIZIO
LEONE, MARIA BARBARA
GIANNOTTA, MARICA
GALIE', NAZZARENO
PALAZZINI, MASSIMILIANO
BACCHI REGGIANI, MARIA LETIZIA
BONO, LEA
POLLINI, GIAN STEFANO

January 2013

Purpose: This study sought to evaluate, by means of a retrospective analysis, the relationship betwe...

w w w.archbronconeumol.org Letters to the Editor Efficacy of Mycophenolate Associated With Methotrexate as a Maintenance Treatment for Systemic Sclerosis-Associated

Interstitial Lung Disease

October 2016

Eficacia del micofenolato asociado a metotrexato como tratamiento de mantenimiento de la enfermedad ...

Intravenous cyclophosphamide pulse therapy in interstitial lung disease associated with systemic sclerosis in a retrospective open-label study: influence of the extent of inflammation on pulmonary function

Abstract

Extracted data

Intravenous cyclophosphamide pulse therapy in interstitial lung disease associated with systemic sclerosis in a retrospective open-label study: influence of the extent of inflammation on pulmonary function

Abstract

Extracted data

Related items

Related items